2 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Advanced Ovarian Clear Cell Adenocarcinoma: new trials by email Literature Review of Advanced Ovarian Clear Cell Adenocarcinoma trials Research Report on Advanced Ovarian Clear Cell Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial Biopsy, Biospecimen Collection, Computed Tomography - Advanced Fallopian Tube Carcinoma, Advanced Fallopian Tube High Grade Serous Adenocarcinoma | Phase 2 | Recruiting | Mayo Clinic | 78 | 2024-11-12 | 2026-10-02 |
| IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel - Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 54 | 2021-09-30 | 2026-10-06 |
Chondrosarcoma (1) · Endometrial Neoplasms (1) · Melanoma (1) · Ovarian Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Adnexal Diseases (1) · Carcinoma (1) · Carcinoma, Squamous Cell (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Gonadal Disorders (1) · Head and Neck Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1)
Bevacizumab (1) · Biopsy (1) · Diphtheria Toxoid (1) · Diphtheria-Tetanus Vaccine (1) · Diphtheria-Tetanus-acellular Pertussis Vaccines (1) · Disulfides (1) · Immunoglobulin G (1) · Leukapheresis (1) · Magnetic Resonance Spectroscopy (1) · Paclitaxel (1) · Specimen Handling (1) · Taxes (1) · Tetanus Toxoid (1) · adacel (1) · capivasertib (1)
M.D. Anderson Cancer Center (1) · Mayo Clinic (1)
United States (2)
Matthew S. Block, MD, PhD (1) · Timothy A Yap, MD (1)